Jan 14, 2026 19:15
LLY - Eli Lilly & Co.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1043.8 17.74 (1.7%) | -1.25 (-0.12%) | -2.73 (-0.26%) | -1.34 (-0.13%) | -2.81 (-0.27%) | 20.54 (1.97%) | 0.75 (0.07%) | -3.26 (-0.31%) |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- 6.3
- Diluted EPS:
- 6.29
- Basic P/E:
- 168.4976
- Diluted P/E:
- 168.7655
- RSI(14) 1m:
- 53.69
- VWAP:
- 1062.22
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jan 14, 2026 18:13
Jan 14, 2026 16:20
Jan 14, 2026 16:15
Jan 14, 2026 13:32
Jan 14, 2026 06:23
Jan 13, 2026 19:33
Jan 13, 2026 18:20
Jan 13, 2026 15:15
Jan 13, 2026 11:30